bioRxivBioengineeringPreprint
Mosaic display of stable hemagglutinin monomers induces broad immune responses
H. Kim, S. C. Min, D. B. Lee, J. H. Jeong, E. J. Kim, J. Y. Maeng, J. H. Seok, J.-H. Lee, Y. Jang, U. S. Jang, T. Ysenbaert, J. P. P. Catani, J. Lee, Y. Lee, Y. K. Kim, G. Lee, J. Y. Mun, H. S. Jun, Y. H. Baek, X. Saelens, J. Lee, M. S. Chung, M.-S. Song, K. H. Kim
Abstract
The nature of the interplay between immunity and viral variation is infinitely adaptive. Infection frequently induces immune responses against variation-prone epitopes, rather than against spatially hidden conserved epitopes. It thus remains a substantial challenge to elicit the immune responses to the conserved epitopes providing broad-spectrum immunity. We developed an approach of scaffold-mediated mosaic display to present monomeric influenza virus hemagglutinins (HAs), which exposes highly conserved stem and interface epitopes. Stable monomers were rationally engineered from H1 and H3 subtypes and B type HA trimers, with amino acid mutations at the monomer-monomer interface and for disulfide bond formation, and fused to a self-assembling scaffold, to generate a mosaic HA monomer-displaying nanoparticle, 3HA-np. Immunization with 3HA-np induced broadly neutralizing antibodies (bnAbs) in mice and ferrets and protected against challenges with H1N1 and H3N2 viruses. Competitive immunoassays revealed that 3HA-np induced high interface- and stem-binding Ab titers as compared to head Ab titers, indicating that the monomeric and mosaic nature of 3HA-np elicit cross-reactive Abs. Our results suggest that exposure of the hidden conserved epitope by monomer-displaying nanoparticles is a promising approach to generate a universal influenza vaccine.
- organism: mouse
- organism: rat
- assay: proteomics
- research focus: drug response / drug discovery
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Elicitation of broadly protective immunity to influenza by multivalent hemagglutinin nanoparticle vaccines
S. Boyoglu-Barnum, D. Ellis, … M. Kanekiyo·bioRxiv·May 30, 2020
- Construction, characterization, and immunization of nanoparticles that display a diverse array of influenza HA trimers
A. A. Cohen, Z. Yang, … P. J. Bjorkman·bioRxiv·Jan 18, 2020
- Designed Nanoparticles Elicit Cross-Reactive Antibody Responses To Conserved Influenza Virus Hemagglutinin Stem Epitopes
D. M. McCraw, M. L. Myers, … A. K. Harris·PLOS PathogensPeer-reviewed·Aug 28, 2023
- Combinatorial immune refocusing within the influenza hemagglutinin head elicits cross-neutralizing antibody responses
A. Dosey, D. Ellis, … N. P. King·bioRxiv·May 23, 2023
- Comparative immunogenicity of bacterially expressed soluble trimers and nanoparticle displayed influenza hemagglutinin stem immunogens
U. Kar, S. Khaleeq, … R. Varadarajan·bioRxiv·Mar 14, 2021
- Single-component self-assembling protein nanoparticles displaying stabilized prefusion-closed hemagglutinin trimers for influenza vaccine development
Yi-Nan Zhang, Xueyong Zhu, … Jiang Zhu·Nature CommunicationsPeer-reviewed·Aug 13, 2026